Neumora Therapeutics, Inc. NMRA 深 沪
等待开盘 02-07 09:30:00 美东时间
2.135
+0.175
+8.93%
华盛通- 最 高2.57
- 今 开2.02
- 成交量 107.20万股
- 最 低 1.50
- 昨 收 1.96
- 总市值 0
- 52周最高 3.25
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.611
- 委 比 5.85%
- 总股本 --
- 历史最高 21.00
- 量 比 1.82
- 振 幅 54.59%
- 历史最低 0.611
- 每 手 1
- 风险率 0.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Neumora's Alzheimer's Agitation Drug Shows Early Promise
NMRA-511 showed promising results in Phase 1b study for Alzheimer's disease agitation with favorable tolerability and safety profile.
01-06 00:11
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-12-01 22:01
瑞穗：核心新药NMRA-861销售有望达12亿美元 上调Neumora(NMRA.US)目标价至5美元
瑞穗分析师Graig Suvannavejh发表研报，将Neumora Therapeutics(NMRA.US)目标价从4美元上调至5美元，并维持“跑赢大盘...
2025-07-21 14:35
Guggenheim Downgrades Neumora Therapeutics to Neutral
Guggenheim analyst Yatin Suneja downgrades Neumora Therapeutics (NASDAQ:NMRA) from Buy to Neutral.
2025-03-10 23:01
Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'
Johnson & Johnson discontinues aticaprant's Phase 3 trial but explores future options. Another depression drug Spravato sales hit $1.01 billion
2025-03-07 22:03
美股异动丨Neumora夜盘涨超8% 忧郁症实验药物最后阶段研究失败
格隆汇1月3日｜Neumora Therapeutics(NMRA.US)隔夜暴跌81.42%后，夜盘涨8.12%，报2.13美元。消息面上，该公司周四表示，治...
2025-01-03 09:57
Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target
Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:NMRA) with a Buy and maintains $23 price target.
2024-09-13 01:31
